In compliance with the guidelines of the Document on Pharmaceutical Governance, the Italian Medicines Agency has decided to set up a permanent consultation table with patient associations within Open AIFA.
In the initiative that has always been dedicated to meetings with all the Agency's interlocutors, AIFA now intends to favor the active involvement of all citizens and patients by reserving an exclusive space for them.
The Agency therefore invites patients, gathered in associations or even individual citizens with issues relating to the drug (e.g. access, research, safety), to contact it at the address openaifa@aifa.gov.it and to consult the dedicated page to view and sign the participation regulation.
The opening of this channel of dialogue represents a valuable contribution to the regulatory activity, because it brings real experiences and skills that will improve the achievement of the primary objective which for AIFA is the promotion and protection of citizens' health.
The agenda and reports will be made available on the Agency's institutional portal.
We remind you that the channel remains open every day for individual patients, healthcare professionals and the general public Pharmalins, to offer an independent and timely information service on contingent issues on authorized medicines.
AIFA. Four strategic guidelines and three major mission objectives accompanied by strategic objectives to be pursued. All with a view to ever greater transparency of information, but also ever more careful and punctual monitoring of the drug.
…
The third objective is the promotion of information and independent scientific research and to encourage investments in R&D in the pharmaceutical sector. In this context, the main strategic objectives are those of managing early access to medicines and promoting clinical research. But also the promotion of culture and independent information on medicines.
For the Minister it would be essential that Aifa prepares “an annual plan of activities in order to guarantee doctors independent information and to strengthen the role of the NHS. In line with the legislation, Aifa prepares an analysis of the scientific information activities on drugs carried out in Italy by pharmaceutical companies, in the field of both general medicine and hospital facilities".
Taken from dailyhealthcare.it
